Patterns of disease activity in systemic lupus erythematosus.
暂无分享,去创建一个
L. Magder | M. Petri | S. Barr | A. Zonana-Nacach | Laurence S Magder | Susan G. Barr | Abraham Zonana-Nacach | Michelle Petri
[1] J. Nossent,et al. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis. , 1998, The Journal of rheumatology.
[2] D. Alarcón-Segovia,et al. Remission of Systemic Lupus Erythematosus , 1996 .
[3] D. Symmons,et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.
[4] D. Gladman,et al. Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flares. , 1994, The Journal of rheumatology.
[5] S. Bombardieri,et al. Activity criteria in systemic lupus erythematosus. , 1994, Clinical and experimental rheumatology.
[6] C. Bombardier,et al. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. , 1994, The Journal of rheumatology.
[7] J. Nossent,et al. Course and prognostic value of Systemic Lupus Erythematosus Disease Activity Index in black Caribbean patients. , 1993, Seminars in arthritis and rheumatism.
[8] J. Carlin,et al. Bias, prevalence and kappa. , 1993, Journal of clinical epidemiology.
[9] D. Sackett,et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.
[10] C. Bombardier,et al. Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. , 1992, The Journal of rheumatology.
[11] M. Petri,et al. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. , 1991, Arthritis and rheumatism.
[12] M. Liang,et al. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. , 1989, Arthritis and rheumatism.
[13] D. Symmons,et al. Development and Assessment of a Computerized Index of Clinical Disease Activity in Systemic Lupus Erythematosus , 1988 .
[14] M. Liang,et al. Measurement of systemic lupus erythematosus activity in clinical research. , 1988, Arthritis and rheumatism.
[15] R. Zwick,et al. Another look at interrater agreement. , 1988, Psychological bulletin.
[16] P. Schur,et al. Serological and clinical remission in systemic lupus erythematosus. , 1985, The Journal of rheumatology.
[17] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[18] D. Gladman,et al. Prolonged complete remission in previously severe SLE. , 1982, Annals of the rheumatic diseases.
[19] M. Ropes. OBSERVATIONS ON THE NATURAL COURSE OF DISSEMINATED LUPUS ERYTHEMATOSUS , 1964, Medicine.
[20] E. Dubois. Systemic lupus erythematosus: recent advances in its diagnosis and treatment. , 1956, Annals of internal medicine.
[21] P. Tumulty. The clinical course of systemic lupus erythematosus. , 1954, Journal of the American Medical Association.
[22] S. Gabriel,et al. A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus. , 1993, The Journal of rheumatology.
[23] M. Petri,et al. Validity and reliability of lupus activity measures in the routine clinic setting. , 1992, The Journal of rheumatology.
[24] A. Feinstein,et al. High agreement but low kappa: II. Resolving the paradoxes. , 1990, Journal of clinical epidemiology.